Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

M D Anderson Cancer Center

M D Anderson Cancer Center in Houston, Texas, United States is listed as a site for 1,631 registered clinical trials, 685 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,631
Ongoing 685

This page covers the site record M D Anderson Cancer Center in Houston, Texas, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the M D Anderson Cancer Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,631 trials counted.

  • Phase 1 306 trials
  • Phase 1/2 158 trials
  • Phase 2 599 trials
  • Phase 2/3 25 trials
  • Phase 3 119 trials
  • Phase 4 11 trials
  • Not applicable 234 trials
  • Observational 178 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 685 trials
  • Completed 644 trials
  • Terminated 270 trials
  • Other 32 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 156

1990: 2 trials (Phase 2 1, Phase 1 1) 1992: 1 trials (Not applicable 1) 1994: 1 trials (Phase 2 1) 1995: 2 trials (Observational 1, Phase 3 1) 1997: 1 trials (Phase 1 1) 1998: 3 trials (Phase 2 1, Phase 1 2) 1999: 5 trials (Observational 2, Phase 3 1, Phase 2 1, Phase 1/2 1) 2000: 15 trials (Observational 1, Phase 3 2, Phase 2/3 1, Phase 2 6, Phase 1/2 2, Phase 1 3) 2001: 11 trials (Observational 1, Phase 2 7, Phase 1/2 1, Phase 1 2) 2002: 14 trials (Phase 3 1, Phase 2 5, Phase 1/2 3, Phase 1 5) 2003: 21 trials (Observational 1, Phase 3 7, Phase 2 8, Phase 1/2 4, Phase 1 1) 2004: 30 trials (Observational 4, Phase 3 3, Phase 2 13, Phase 1/2 4, Phase 1 6) 2005: 26 trials (Observational 3, Phase 3 5, Phase 2 6, Phase 1/2 4, Phase 1 8) 2006: 35 trials (Observational 2, Not applicable 3, Phase 3 4, Phase 2/3 1, Phase 2 16, Phase 1/2 2, Phase 1 7) 2007: 39 trials (Other 1, Observational 4, Not applicable 1, Phase 3 5, Phase 2 20, Phase 1/2 3, Phase 1 5) 2008: 19 trials (Observational 1, Not applicable 1, Phase 3 4, Phase 2 9, Phase 1 4) 2009: 38 trials (Observational 3, Not applicable 4, Phase 3 9, Phase 2 13, Phase 1/2 2, Phase 1 7) 2010: 38 trials (Observational 1, Not applicable 4, Phase 3 7, Phase 2 15, Phase 1/2 3, Phase 1 8) 2011: 40 trials (Observational 4, Not applicable 6, Phase 2 21, Phase 1/2 1, Phase 1 8) 2012: 60 trials (Observational 5, Not applicable 5, Phase 3 11, Phase 2/3 2, Phase 2 18, Phase 1/2 6, Phase 1 13) 2013: 53 trials (Observational 8, Not applicable 5, Phase 3 6, Phase 2 19, Phase 1/2 5, Phase 1 10) 2014: 64 trials (Observational 2, Not applicable 5, Phase 3 5, Phase 2/3 6, Phase 2 27, Phase 1/2 5, Phase 1 14) 2015: 88 trials (Observational 6, Not applicable 12, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 36, Phase 1/2 8, Phase 1 17) 2016: 80 trials (Observational 6, Not applicable 13, Phase 3 2, Phase 2 42, Phase 1/2 3, Phase 1 14) 2017: 129 trials (Observational 9, Not applicable 18, Phase 4 2, Phase 3 5, Phase 2/3 3, Phase 2 60, Phase 1/2 12, Phase 1 20) 2018: 135 trials (Observational 5, Not applicable 28, Phase 4 2, Phase 3 5, Phase 2/3 3, Phase 2 49, Phase 1/2 11, Phase 1 32) 2019: 155 trials (Observational 23, Not applicable 32, Phase 4 1, Phase 3 7, Phase 2/3 5, Phase 2 39, Phase 1/2 17, Phase 1 31) 2020: 147 trials (Observational 32, Not applicable 25, Phase 4 2, Phase 3 5, Phase 2 46, Phase 1/2 16, Phase 1 21) 2021: 156 trials (Observational 27, Not applicable 31, Phase 3 5, Phase 2/3 1, Phase 2 46, Phase 1/2 19, Phase 1 27) 2022: 82 trials (Observational 12, Not applicable 15, Phase 4 1, Phase 3 1, Phase 2/3 1, Phase 2 28, Phase 1/2 11, Phase 1 13) 2023: 93 trials (Observational 10, Not applicable 16, Phase 4 2, Phase 3 7, Phase 2/3 1, Phase 2 25, Phase 1/2 12, Phase 1 20) 2024: 33 trials (Observational 3, Not applicable 6, Phase 3 3, Phase 2 14, Phase 1/2 3, Phase 1 4) 2025: 6 trials (Not applicable 1, Phase 3 1, Phase 2 3, Phase 1 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 7
2025 6
2024 33
2023 93
2022 82
2021 156
2020 147
2019 155
2018 135
2017 129

Showing 10 of 34 years.

Start your 14-day trial Email me all 34 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,631 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 73 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 379 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF